300 related articles for article (PubMed ID: 10874013)
1. In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline.
King RS; Teitel CH; Kadlubar FF
Carcinogenesis; 2000 Jul; 21(7):1347-54. PubMed ID: 10874013
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse.
Leff MA; Epstein PN; Doll MA; Fretland AJ; Devanaboyina US; Rustan TD; Hein DW
J Pharmacol Exp Ther; 1999 Jul; 290(1):182-7. PubMed ID: 10381774
[TBL] [Abstract][Full Text] [Related]
3. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice.
Lin DX; Lang NP; Kadlubar FF
Drug Metab Dispos; 1995 Apr; 23(4):518-24. PubMed ID: 7600922
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
5. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland.
Sadrieh N; Davis CD; Snyderwine EG
Cancer Res; 1996 Jun; 56(12):2683-7. PubMed ID: 8665493
[TBL] [Abstract][Full Text] [Related]
6. N-acetyltransferase-dependent activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine: formation of 2-amino-1-methyl-6-(5-hydroxy)phenylimidazo [4,5-b]pyridine, a possible biomarker for the reactive dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Frandsen H; Alexander J
Carcinogenesis; 2000 Jun; 21(6):1197-203. PubMed ID: 10837010
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Syrian hamsters congenic at the N-acetyltransferase 2 (NAT2) locus.
Fretland AJ; Devanaboyina US; Doll MA; Zhao S; Xiao GH; Hein DW
Toxicol Sci; 2003 Aug; 74(2):253-9. PubMed ID: 12773763
[TBL] [Abstract][Full Text] [Related]
8. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
9. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1.
Ross MK; Pegram RA
Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683
[TBL] [Abstract][Full Text] [Related]
10. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
11. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.
Nelson CP; Kidd LC; Sauvageot J; Isaacs WB; De Marzo AM; Groopman JD; Nelson WG; Kensler TW
Cancer Res; 2001 Jan; 61(1):103-9. PubMed ID: 11196146
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.
Turesky RJ; Lang NP; Butler MA; Teitel CH; Kadlubar FF
Carcinogenesis; 1991 Oct; 12(10):1839-45. PubMed ID: 1934265
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).
Chou HC; Lang NP; Kadlubar FF
Cancer Res; 1995 Feb; 55(3):525-9. PubMed ID: 7834621
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4, 5-f]quinoline.
Agus C; Ilett KF; Kadlubar FF; Minchin RF
Carcinogenesis; 2000 Jun; 21(6):1213-9. PubMed ID: 10837012
[TBL] [Abstract][Full Text] [Related]
15. N-Acetyltransferase and sulfotransferase activity in human prostate: potential for carcinogen activation.
Al-Buheissi SZ; Patel HR; Meinl W; Hewer A; Bryan RL; Glatt H; Miller RA; Phillips DH
Pharmacogenet Genomics; 2006 Jun; 16(6):391-9. PubMed ID: 16708048
[TBL] [Abstract][Full Text] [Related]
16. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis.
Kadlubar F; Kaderlik RK; Mulder GJ; Lin D; Butler MA; Teitel CH; Minchin RF; Ilett KF; Friesen MD; Bartsch H
Princess Takamatsu Symp; 1995; 23():207-13. PubMed ID: 8844812
[TBL] [Abstract][Full Text] [Related]
20. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]